I have read many of Chris Kallos's MST research reports over the years , and he's always been level headed and pragmatic in his reviews ...
.... but , lest we lose sight of the main issue here : Improving health outcomes for patients .... CYP has achieved a very positive result in a trial to improve the healing of diabetics with foot ulcer wounds ... this is an extremely awesome thing for those folks who are suffering ... which also includes us long time shareholders ...
- Forums
- ASX - By Stock
- CYP
- Ann: Encouraging Initial Data from CYP-006TK DFU Trial
Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-50
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 24.5¢ | $12.66K | 50.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20209 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 36715 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20209 | 0.250 |
2 | 49573 | 0.245 |
2 | 102000 | 0.240 |
1 | 100000 | 0.235 |
2 | 15173 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 36715 | 1 |
0.265 | 8119 | 2 |
0.270 | 30000 | 1 |
0.290 | 1900 | 1 |
0.295 | 183892 | 1 |
Last trade - 15.43pm 25/07/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |